Pular para o conteúdo
Merck

Dietary nitrate and nitrite intake and risk of colorectal cancer in the Shanghai Women's Health Study.

International journal of cancer (2013-11-19)
Curt T Dellavalle, Qian Xiao, Gong Yang, Xiao-Ou Shu, Briseis Aschebrook-Kilfoy, Wei Zheng, Hong Lan Li, Bu-Tian Ji, Nathaniel Rothman, Wong-Ho Chow, Yu-Tang Gao, Mary H Ward
RESUMO

Nitrate and nitrite are precursors of endogenously formed N-nitroso compounds (NOC), known animal carcinogens. Nitrosation reactions forming NOCs can be inhibited by vitamin C and other antioxidants. We prospectively investigated the association between dietary nitrate and nitrite intake and risk of colorectal cancer in the Shanghai Women's Health Study, a cohort of 73,118 women ages 40-70 residing in Shanghai. We evaluated effect modification by factors that affect endogenous formation of NOCs: vitamin C (at or above/below median) and red meat intake (at or above/below median). Nitrate, nitrite and other dietary intakes were estimated from a 77-item food frequency questionnaire administered at baseline. Over a mean of 11 years of follow-up, we identified 619 colorectal cancer cases (n = 383, colon; n = 236, rectum). Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using Cox proportional hazard regression. Overall, nitrate intake was not associated with colorectal cancer risk (HR = 1.08; 95% CI: 0.73-1.59). However, among women with vitamin C intake below the median (83.9 mg day(-1) ) and hence higher potential exposure to NOCs, risk of colorectal cancer increased with increasing quintiles of nitrate intake (highest vs. lowest quintile HR = 2.45; 95% CI: 1.15-5.18; p trend = 0.02). There was no association among women with higher vitamin C intake. We found no association between nitrite intake and risk of colorectal cancer overall or by intake level of vitamin C. Our findings suggest that high dietary nitrate intake among subgroups expected to have higher exposure to endogenously formed NOCs increases risk of colorectal cancer.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Ácido L-ascórbico, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
Ácido L-ascórbico, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
L-ascorbato de (+)-sódio, crystalline, ≥98%
Sigma-Aldrich
Ácido L-ascórbico, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
L-ascorbato de (+)-sódio, BioXtra, ≥99.0% (NT)
Sigma-Aldrich
L-ascorbato de (+)-sódio, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Ácido L-ascórbico, reagent grade, crystalline
Sigma-Aldrich
Ácido L-ascórbico, 99%
Supelco
Ácido L-ascórbico, analytical standard
Supelco
Ácido ascórbico, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ácido L-ascórbico, reagent grade
Sigma-Aldrich
Ácido L-ascórbico, ACS reagent, ≥99%
Sigma-Aldrich
Ácido L-ascórbico, meets USP testing specifications
Sigma-Aldrich
Ácido L-ascórbico, FCC, FG
Supelco
L-ascorbato de (+)-sódio, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ácido L-ascórbico, BioUltra, ≥99.5% (RT)
Sigma-Aldrich
Ácido L-ascórbico, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Ácido L-ascórbico, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Ácido L-ascórbico, tested according to Ph. Eur.
Supelco
Ácido L-ascórbico, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Ácido L-ascórbico, puriss. p.a., ≥99.0% (RT)
L-ascorbato de (+)-sódio, European Pharmacopoeia (EP) Reference Standard